57.08
Nektar Therapeutics Aktie (NKTR) Neueste Nachrichten
Will Nektar Therapeutics stock benefit from AI adoptionJuly 2025 Volume & Growth Focused Stock Reports - newser.com
Using economic indicators to assess Nektar Therapeutics potential2025 Pullback Review & Reliable Breakout Forecasts - newser.com
Why retail investors pile into Nektar Therapeutics stock2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Evaluating Nektar Therapeutics with trendline analysisJuly 2025 PreEarnings & AI Enhanced Trading Alerts - newser.com
Why Nektar Therapeutics Rippled Higher This Week - MSN
Is Nektar Therapeutics stock a good choice for value investorsShort Setup & Weekly Chart Analysis and Guides - newser.com
How Investors Are Reacting To Nektar Therapeutics (NKTR) Securing FDA Fast Track For Eczema Drug Candidate - simplywall.st
FDA Fast Track for Eczema Therapy Could Be a Game Changer for Nektar Therapeutics (NKTR) - Yahoo Finance
Nektar Therapeutics (NKTR): Assessing Valuation After a Strong Multi-Month Share Price Rally - Yahoo Finance
Best data tools to analyze Nektar Therapeutics stockJuly 2025 Breakouts & Precise Trade Entry Recommendations - newser.com
This Stock Is Up By 285% This Year But Could Still Jump By 53%, According to Wall Street - AOL.com
Custom strategy builders for tracking Nektar TherapeuticsVolume Spike & Expert Curated Trade Setups - newser.com
Quantitative breakdown of Nektar Therapeutics recent moveQuarterly Portfolio Report & High Accuracy Trade Signal Alerts - newser.com
Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September - MSN
Wealth Enhancement Advisory Services LLC Reduces Stake in Nektar Therapeutics $NKTR - MarketBeat
Why Nektar Therapeutics Stock Zoomed More Than 15% Higher Today - MSN
Nektar Therapeutics' (NKTR) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
What MACD and RSI say about Nektar TherapeuticsJuly 2025 Fed Impact & Smart Money Movement Tracker - newser.com
Moderate to Severe Atopic Dermatitis Pipeline Drugs Insights Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight - The Globe and Mail
How Nektar Therapeutics (ITH0) stock responds to job market shiftsNew Guidance & Reliable Price Breakout Alerts - newser.com
Sector ETF performance correlation with Nektar Therapeutics2025 Technical Patterns & AI Driven Price Predictions - newser.com
Gainplan LLC Buys New Shares in Nektar Therapeutics $NKTR - MarketBeat
Public Employees Retirement System of Ohio Sells 121,001 Shares of Nektar Therapeutics $NKTR - MarketBeat
Nektar Therapeutics (NKTR): Examining Valuation After Breakthrough Eczema Drug Trial Results Spark Investor Interest - Sahm
How Nektar Therapeutics (ITH0) stock reacts to weak economyDividend Hike & Real-Time Stock Movement Alerts - newser.com
What analysts say about Nektar Therapeutics stockSwing Trading Watchlist & Build Wealth With Expert Timing Advice - earlytimes.in
Real time social sentiment graph for Nektar TherapeuticsTrade Entry Report & Fast Exit and Entry Strategy Plans - newser.com
Is a relief rally coming for Nektar Therapeutics holdersTrade Entry Summary & Advanced Swing Trade Entry Plans - newser.com
How analysts rate Nektar Therapeutics stock today2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Why Nektar Therapeutics (NKTR) Is Up 8.8% After Positive Phase 2b Rezpegaldesleukin Data at EADV - simplywall.st
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):